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ABSTRACT
Objective: A substantial proportion of patients develop posttraumatic stress
disorder (PTSD) following myocardial infarction (MI). Previous research on
the trajectory over time of PTSD in post-MI patients is scant and refers to
self-rated posttraumatic symptoms. The aim of this study was to investigate
the longitudinal course of an interviewer-rated diagnosis of PTSD and PTSD
symptom severity following MI. Methods: Study participants were 40
patients (78% men, mean age 54 ± 8 years) who were diagnosed with PTSD
using the Clinician-administered PTSD Scale (CAPS) after an average of
5 ± 4 months (range 2-16 months) following an index MI. After a mean
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follow-up of 26 ± 6 months (range 12-36 months), 24 patients underwent a
second diagnostic interview. Results: Two-thirds of patients (n = 16) still
qualified for a diagnosis of PTSD at follow-up. In all 24 patients, total
PTSD symptoms (p = 0.001), re-experiencing symptoms (p < 0.001), avoid-
ance symptoms (p = 0.015), and, with borderline significance, hyperarousal
symptoms (p < 0.06) had all decreased over time. However, in the subgroup
of the 16 patients who had retained PTSD diagnostic status at follow-up,
symptoms of avoidance (p = 0.23) and of hyperarousal (p = 0.48) showed no
longitudinal decline. Longer duration of follow-up was associated with a
greater decrease in avoidance symptoms (p = 0.029) and, with borderline
significance, in re-experiencing symptoms (p < 0.07) across all patients.
Conclusion: Although PTSD symptomatology waned over time and in rela-
tion to longer follow-up, two-thirds of patients still qualified for a diagnosis
of PTSD 2 years after the initial diagnosis. In post-MI patients, clinical PTSD
is a considerably persistent condition.
(Int’l. J. Psychiatry in Medicine 2009;39:359-376)
Key Words: cardiovascular disease, longitudinal, psychiatry, psychological stress
INTRODUCTION
Patients may experience a myocardial infarction (MI) as a veritable trauma that is
accompanied by loss of control and high levels of distress [1, 2]. When traumatic
distress elicited by MI reaches a certain degree and lasts for at least one month, the
patient might qualify for a diagnosis of posttraumatic stress disorder (PTSD) [3].
According to the Diagnostic and Statistical Manual of Mental Disorders, fourth
edition (DSM-IV), the definition of PTSD requires threatened death triggered
by an extreme stressor to which an individual responded with intense fear or
helplessness [4]. In addition to the exposure to a life-threatening cardiac event
(criterion A), the MI patient with PTSD must re-experience the MI (e.g., in form
of distressing dreams during which the MI is replayed; criterion B), avoid
reminders for aspects of the MI (e.g., intake of cardiac drugs; criterion C), and
have symptoms of heightened physiological arousal such as perturbed sleep
(criterion D) [3, 4]. The mean prevalence of PTSD was 15% (range 0-25%) in a
previous review on 13 studies that totally included 827 post-MI patients [3]. A
more recent study suggested that this prevalence might even be higher, reporting
72% of self-rated full and partial PTSD combined in 96 older post-MI patients
[5]. Studies applying a clinical interview as opposed to self-rated questionnaires
to diagnose PTSD caused by MI find slightly lower prevalence rates of about
10% on average [6-11]. Patients who developed PTSD following MI showed a
higher rate of cardiovascular readmissions within the first year post-MI [12] and
lower adherence to cardiovascular drug therapy [13]. Taken together, PTSD
related to MI is increasingly acknowledged as a prevalent and clinically important
comorbid psychiatric disorder in MI patients [3, 14, 15].
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Several studies find symptoms of acute stress disorder and general psycho-
logical distress at hospital admission or in the first days after MI predict PTSD
[16-18]. However, longitudinal studies assessing PTSD following MI at several
points in time are scarce, did not assess the course of PTSD beyond 18 months
after MI, and also did not assess PTSD using structured clinical interviews [3].
One study found a non-significant decrease of 40% in self-rated PTSD between
4-6 weeks and 9 months in 102 post-MI patients [19]. In 213 and 179 patients,
respectively, with an acute coronary syndrome, self-reported PTSD was found
in 12% 1 year after the cardiac event and in 13% at the 3-year follow-up; among
patients with a classic ST-elevation MI, the prevalence of PTSD was 10% 1-year
post-MI but not reported for the 3-year follow-up [20].
The present study aimed to extend the current knowledge on PTSD attributable
to MI by several novel aspects. Specifically, we investigated the trajectory of
MI-related PTSD as diagnosed by a standardized clinical interview beyond an
observation period of 1 year. Our previous review suggested an inverse although
not significant relationship between the time elapsed since MI and prevalence
of PTSD [3]. However, most studies diagnosed PTSD within the first half year
after MI which period might be too short for evident waning of PTSD symptoms
[3]. Longitudinal research on war veterans and accident victims indeed suggests
that self-rated PTSD symptoms often persist at high levels over many years
[21-23]. Moreover, in severely injured accident victims the prevalence of an
interviewer-rated diagnosis of PTSD (full and subthreshold PTSD combined)
was 12% after 1 year and 13% after 3 years [24]. Of 16 Holocaust survivors
with the diagnosis of an interviewer-assessed PTSD, only three had remitted
10 years later [25].
Because PTSD is a chronic condition by definition, sufficiently long obser-
vation periods may be required to see a significant decline in its prevalence
and severity. Therefore, we hypothesized that PTSD would show considerable
persistence such that only a portion of post-MI patients would remit from PTSD
over time on one hand, but that PTSD symptom severity would decrease in
relation to the duration of follow-up on the other.
METHODS
Study Participants and Recruitment
All patients provided written informed consent to the study protocol, which
was approved by the ethics committee of the State of Bern, Switzerland, as part
of the ongoing longitudinal Swiss Heart and Mind Study. The flowchart of
recruitment is outlined in Figure 1. Recruitment has previously been detailed as
concerns the identification of the 40 patients with diagnostic PTSD following
MI [10, 11] who were followed-up for the present study.
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Figure 1. The flowchart illustrates the recruitment procedure for the
24 patients with diagnostic posttraumatic stress disorder (PTSD) following
myocardial infarction (MI) undergoing the clinician-administered PTSD
(CAPS) interview after a mean follow-up of 2 years.
426 returned PDS screening questionnaire
394 screened for PTSD
77 with PDS score  15 points
40 with interviewer-rated PTSD at entry
24 available for follow-up interview
951 eligible patients with index MI approached
PDS: posttraumatic diagnostic scale
7 no time
6 no interest
1 somatic comorbidity
1 could not be reached
1 died
317 with PDS score < 15 points
525 did not respond to survey
16 had died
16 declined to participate
8 declined the CAPS interview
29 without PTSD following the CAPS
In brief, 951 consecutive patients referred to the Department of Cardiology,
University of Bern, Switzerland, were approached between 01/2005 and 04/2007,
if they had a verified ST-elevation or non-ST-elevation MI according to previous
guidelines [26]. Further eligibility criteria were living within a 90-min ride by
car or by train from the University Hospital and to speak German sufficiently.
Demographic (sex, age) and cardiac variables were abstracted from hospital
charts. The latter were index MI, type of index MI (first-time vs. recurrent MI),
left ventricular ejection fraction (LVEF) as measured by ventriculography during
coronary angiography, the number of coronary occlusions (1- vs. 2- or 3-vessel
disease), and highest level of total serum creatinine kinase (CK).
On average 3 months after the index MI, all 951 patients were mailed home the
German version of the posttraumatic diagnostic scale (PDS) [27] and a three-item
questionnaire to retrospectively rate on a Likert scale (0-10) perceived fear of
dying, helplessness, and pain during the index MI. The PDS focuses on the 17
posttraumatic stress symptoms according to DSM-IV criteria [28]; each item is
rated on a Likert scale (0-3) yielding a maximum PTSD symptom score of 51.
The German version of the PDS shows good internal consistency for the total
scale (Cronbachs’  = .94) and for each of the three PTSD symptom clusters
(Cronbachs’  = .88-.90) [29]. Patients who scored at least 15 points on the PDS
[30] were invited to undergo a structured interview applying the Clinician-
administered PTSD Scale (CAPS) (cf. below). We previously reported that 40
patients (10.2%) of the 394 patients screened with the PDS qualified for a
DSM-IV diagnosis of either full or subthreshold PTSD based on the first CAPS
interview [11]. In contrast the 12-month prevalence of subthreshold PTSD was
1.3% and that for full PTSD was 0% in a representative community-based cohort
in Switzerland [31]; these low rates guided us to not screen for PTSD symptoms
prior to MI condition. Moreover, the PDS and CAPS interview specifically asked
for MI being the potentially traumatic event. We particularly replaced the term
“event” with the term “heart attack” in the PDS questionnaire as previously
reported [10, 32]. Therefore, the observed prevalence of PTSD in our sample is
unlikely diluted by traumatic experiences other than MI.
Follow-Up Investigation
The 40 post-MI patients with an interviewer-diagnosed PTSD were mailed
home a letter between 1 and 3 years after the initial PTSD diagnosis. They were
asked for their willingness to volunteer in a follow-up investigation on the
longitudinal course of PTSD. If a patient did not respond to the written invitation,
we additionally contacted him or her by phone. At the time, the reasons for why
a patient declined to participate (Figure 1) and medical events, which occurred
during the follow-up period, were noted. One patient who had been diagnosed
with primary Cushing’s syndrome since the first CAPS interview was excluded
from the follow-up interview because cortisol has strongly been implied in the
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psychopathology of PTSD [33]. Altogether, 24 patients consented to and were
eligible for the follow-up investigation.
Clinician-Administered PTSD Scale (CAPS)
The CAPS is a structured psychometric interview, which has been developed
by the National Center for PTSD to diagnose current and lifetime PTSD as
defined in DSM-IV [34]. The frequency and intensity of each of the 17 PTSD
symptoms are quantified on a 5-point scale ranging between “never” (0 points) to
“almost always” (4 points). A particular symptom is given when rated with a fre-
quency of  1 point and an intensity of  2 points. To meet diagnostic criteria for
a particular symptom cluster, one of five symptoms must be given for criterion B
(re-experiencing subscale), three of seven symptoms for criterion C (avoidance
subscale), and two of five symptoms for criterion D (hyperarousal subscale).
The CAPS symptom subscales provide a continuous measure of PTSD symptom
severity. Overall severity of PTSD is obtained by adding up symptom scores
of criteria B + C + D to a total PTSD symptom score. Patients were diagnosed
with full (i.e., syndromal) PTSD if they met criteria B, C, and D altogether, and
with subthreshold (i.e., subsyndromal) PTSD if they met criterion B plus either
criterion C or D [35]. We applied the German version of the CAPS which
shows good internal consistency for the severity score of all 17 items of PTSD
(Cronbach’s  =.88-.92) and for each of the three PTSD symptom clusters
( = .73-.88) [36].
Statistical Analysis
Data were analyzed using the SPSS 15.0 statistical software package (SPSS
Inc. Chicago, IL). Level of significance was set at p < 0.05 (two-tailed). All data
are provided in original units. Because several variables were not normally
distributed, we applied non-parametric statistics throughout. Specifically, we
used Mann-Whitney U test and Fisher’s exact test, respectively, to test for
differences in continuous and categorical data between two groups. The Spearman
rank test was used to estimate the correlation between two variables.
RESULTS
Patient Characteristics
The demographic, medical, and psychometric characteristics assessed at study
entry of the 24 patients who consented to the follow-up interview and the 16
patients who were not available at follow-up are given in Table 1. There were no
significant differences in any of these variables between the two groups. Four
patients reported to take antidepressant medication at follow-up (two had full
PTSD and two had no diagnostic PTSD at follow-up). Two of these patients also
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reported that they had undergone psychotherapy during follow-up (one started
psychotherapy yet before the index MI). They did not mention that trauma-
specific elements had been applied by the psychotherapist. During follow-up,
there occurred no acute cardiovascular events requiring hospital admission.
However, three patients reported to have undergone elective coronary stenting,
which procedure took place 4, 14, and 32 months, respectively, after the index MI.
Trajectory of PTSD Diagnosis
As previously reported [11], full PTSD was present in 14 patients (35%)
and subthreshold PTSD was found in 26 patients (65%) at study entry. Of the 24
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Table 1. Characteristics of 40 Myocardial Infarction Patients
with Diagnostic PTSD
Available for follow-up interview
Variables Yes (n = 24) No (n = 16) P
Sex (% men)
Age (years)
First-time myocardial infarction (%)
2- or 3-vessel disease (%)
Left ventricular ejection fraction (%)
Highest serum total creatine
kinase level (U/l)
Posttraumatic diagnostic scale (score)
Fear of dying (score)
Feelings of helplessness (score)
Perceived pain (score)
CAPS interview after index infarction
(months)
Total CAPS symptoms (score)
CAPS re-experiencing symptoms
(score)
CAPS avoidance symptoms (score)
CAPS hyperarousal symptoms (score)
79
55.6 ± 7.1
87
33
52.1 ± 9.4
1326 ± 1304
26.7 ± 8.7
6.4 ± 3.0
6.6 ± 2.9
7.3 ± 2.6
4.2 ± 3.2
53.0 ± 21.6
18.3 ± 7.5
18.7 ± 9.8
16.7 ± 7.6
75
51.3 ± 7.8
94
31
51.3 ± 10.4
1641 ± 1851
28.6 ± 9.6
7.2 ± 3.1
8.0 ± 2.8
7.8 ± 2.6
5.0 ± 4.2
50.8 ± 20.2
18.1 ± 6.2
17.9 ± 11.6
14.7 ± 8.0
1.000
0.113
0.638
1.000
0.754
0.929
0.521
0.344
0.070
0.454
0.989
0.902
0.860
0.637
0.595
Values are given as means ± SD.
CAPS: clinician-administered posttraumatic stress disorder (PTSD) scale.
patients who were available for the follow-up interview, 11 (46%) and 13 (54%),
respectively, had full and subthreshold PTSD at entry. The percentage of full
PTSD at study entry was not different between patients participating and those not
participating in the follow-up (p = 0.101).
On average, patients had experienced the index MI 30.4 ± 6.9 months (range
14-42 months) prior to the follow-up interview. The mean follow-up between
the entry and follow-up CAPS interviews was 26.2 ± 6.5 months (range 12-36
months). At follow-up, two-thirds of patients (67%) still qualified for a diagnosis
of PTSD, which was full PTSD in eight cases (at entry: five full PTSD, three
subthreshold PTSD) and subthreshold PTSD in another eight cases (at entry: three
full PTSD, five subthreshold PTSD). Eight patients (33%) no longer fulfilled
diagnostic criteria for PTSD at follow-up (at entry: three full PTSD, five sub-
threshold PTSD). The change in diagnostic PTSD status from study entry (all
24 patients having PTSD) to follow-up (16 patients having PTSD) was significant
(p = 0.005).
Trajectory of Severity of PTSD Symptoms
In all 24 patients, entry and follow-up scores of CAPS total symptoms (r = 0.61,
p = 0.002), avoidance symptoms (r = 0.64, p = 0.001), and hyperarousal symptoms
(r = 0.43, p = 0.042), but not re-experiencing symptoms (r = 0.32, p = 0.13), were
significantly correlated with each other. Table 2 shows the change in total PTSD
symptoms as well as in the individual PTSD symptom domains. There was no
significant difference in any symptom score assessed at study entry between
patients with and those without diagnostic PTSD at follow-up (p > 0.05). Among
all 24 patients, there was a significant decrease in total symptoms, re-experiencing
symptoms, and avoidance symptoms, and with borderline significance in hyper-
arousal symptoms, from entry to follow-up. Figure 2 depicts the trajectory of total
CAPS symptoms (panel A) and of individual symptom domains (panels B-D)
for each patient. In contrast to the eight patients who no longer fulfilled criteria
for diagnostic PTSD at follow-up (to the right in Figure 2 A-D), symptoms of
avoidance and of hyperarousal did not significantly decrease in the 16 patients
who kept a diagnosis of PTSD.
Correlates of Change in PTSD Symptoms
Longer duration of follow-up (months between entry and follow-interviews)
was significantly associated with a greater decrease over time in avoidance
symptoms (r = 0.45, p = 0.029; explained variance 20%) and, with borderline
significance, in re-experiencing symptoms (r = 0.39, p < 0.07; explained variance
15%). In contrast, duration of follow-up was not significantly associated with
changes in total PTSD symptoms (r = 0.31, p = 0.14) and hyperarousal symptoms
(r = 0.15, p = 0.49) over time. Perceived fear of dying, helplessness, and pain
during the index MI were all not significantly associated with changes in total
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PTSD symptoms, re-experiencing symptoms, avoidance symptoms, and hyper-
arousal symptoms. Likewise, demographic factors (sex, age) and objective factors
of cardiac disease severity (LVEF, number of diseased vessels, highest levels of
CK during MI) were not significantly associated with longitudinal changes in
any PTSD symptom score (data not shown).
DISCUSSION
We performed a follow-up interview with 24 patients who had developed full
or subthreshold diagnostic PTSD in response to an index MI 2 years previous.
The decrease in the percentage of patients showing remission from diagnostic
PTSD at follow-up (i.e., 33%) was statistically significant. Nonetheless, we found
that two-thirds of patients still qualified for an interviewer-rated diagnosis of
PTSD 2 years after the initial diagnosis. An equal number of full and subthreshold
PTSD was found across the two assessments among the latter group. A detailed
analysis revealed a change between study entry and follow-up from full to
subthreshold PTSD and vice versa in three cases. This observation concurs
with the course of PTSD in non-cardiac populations, in which a categorical
diagnosis of PTSD showed a waxing and waning course but, at large, persisted
over time. For instance, in 90 accident victims followed for 3 years, there was
an increase from two cases of full PTSD at 1 year to four cases at 3 years and a
decrease of one case with full PTSD to subthreshold PTSD during the same period
[24]. In 28 Holocaust survivors followed for 10 years, diagnostic PTSD status
changed in six subjects with 3 of 12 cases developing PTSD and with 3 of 16
cases remitting [25].
In terms of continuous measures of posttraumatic symptom severity, we found
that, across all 24 subjects, levels of total PTSD symptoms, re-experiencing
symptoms, and avoidance symptoms significantly decreased over time, whereas
the decline in hyperarousal symptoms was of borderline significance. Interestingly
enough, looking at patients who qualified for a diagnostic status of PTSD in both
interviews as a separate group, it appeared to be avoidance and hyperarousal
symptoms which contributed most to the maintenance of the diagnosis since these
two symptom clusters did not significantly decrease over time. In contrast, the
subgroup no longer qualifying for a PTSD diagnosis at follow-up had signifi-
cantly decreased levels of PTSD symptoms in all three clusters. These observa-
tions partially concur with a previous study in which avoidance symptoms, but
not hyperarousal symptoms, had decreased in 98 survivors of a motor vehicle
accident 6 months after the event [37]. In 413 survivors of community violence, all
PTSD symptom clusters decreased over time, whereby re-experiencing symptoms
showed the most rapid decrease and more hyperarousal symptoms predicted
lower overall improvement [38].
We found that the duration of follow-up predicted the magnitude of
change in PTSD symptom severity from study entry to follow-up across all
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patients. Specifically, a longer follow-up was associated with significantly less
avoidance symptoms and, with a trend toward statistical significance, also with
less re-experiencing symptoms explaining 20% and 15%, respectively, of the
variance. However, there was little evidence for a significant decrease in hyper-
arousal symptoms in relation to the duration of follow-up. We offer one possible
explanation for this distinct relationship between individual PTSD symptom
clusters and duration of follow-up. The long-term impact of a heart attack on the
time course of posttraumatic distress might differ from that exerted by other
types of trauma which do not have their onset in a person’s body. It is overly
difficult to avoid the perception of the heart as an organ that is perceived through
its mechanic action and through issues related to the heart disease, such as
cardiac therapies and cardiology visits. Post-MI patients with PTSD are exposed
to their heart virtually from one heartbeat to the next. Although this needs
to be demonstrated, the inescapable confrontation of a patient with his or her
heart issues might force natural desensitization toward symptoms assigned to
malfunction of the heart. This effect may increase as more time elapses since the
traumatizing event of a heart attack. On the contrary, hyperarousal symptoms
are less specific to a traumatic experience and might overlap with physiological
alterations accompanying state and trait negative affect, particularly anger,
anxiety, and depression, all of which are prevalent in MI patients [39, 40].
Negative affect, particularly depression that frequently co-occurs with PTSD
[41], correlates with subjective sleep complaints, including sleep-onset and sleep-
maintenance insomnia [42], both being definition criteria of the PTSD hyper-
arousal cluster [4]. Even when PTSD-related hyperarousal decreases over time,
hyperarousal symptoms as a whole might sustain because of their many non-
PTSD specific contributors in post-MI patients.
A particular strength of our study is that we used a standard psychiatric
interview to define PTSD, in comparison with most studies that have used
self-reported questionnaires [3]. Moreover, the course of PTSD symptomatology
caused by MI and acute coronary syndromes, respectively, has been assessed
in only two previous studies, which, however, did not apply a standardized
clinical interview and also did not extend the observation period beyond 18
months [17, 18]. Nonetheless, the interpretations and implications of our findings
need to be discussed within the limitations of the study design, particularly the
sample size. We initially screened 951 MI patients, of whom 41% had relevant
screenings. Of these, our final sample included the 40 (10.2%) patients who
met DSM-IV diagnostic criteria for PTSD. Moreover, of these 40 patients, 24
participated in the second interview to assess the course of post-MI PTSD.
Clearly, this loss to follow-up further reduced both the percentage of incidence in
diagnostic course and sustained diagnosis. On the other hand, these 24 patients
did not differ in their characteristics from the 16 patients with PTSD who were
not available for the follow-up investigation (Table 1). The rate of patients
consenting to the initial screening for PTSD symptomatology was comparable to
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similar previous surveys also mailing PTSD symptom questionnaires to patients
and showing response rates of about 60% [18, 43]. Nonetheless, we acknowledge
that the low response rate in the first wave of assessment, yielding 40 patients
with PTSD, and the further attrition in the second wave, eventually yielding 24
respondents, raises the concern of a biased sample and questions the general-
izability of findings.
We did not assess previously identified predictors of PTSD trajectories over
time, such as co-morbid depression [44], cognitive factors [45], and concurrent
life stress [46]. Focusing solely on PTSD symptomatology in post-MI patients
does only provide a narrow snap shot of clinical reality. Subjective perception of
the MI, as well as demographic and cardiac variables, showed no relationship
with the longitudinal course of PTSD symptoms in our patients. However, it was
not the focus of our study to identify significant predictors of a longitudinal change
in PTSD diagnosis and symptoms because statistical power was clearly too low
for this purpose. Therefore, we feel it premature to discount the potential clinical
importance of any covariates in predicting trajectories of a PTSD diagnosis and
PTSD symptom severity in post-MI patients. Our design allowed us to solely
investigate change in diagnostic PTSD status in patients who already had PTSD at
study entry. Some patients scoring above the cut-off for PTSD symptoms at
screening, but who did not have PTSD based on the first interview, might have
developed late onset PTSD during follow-up that escaped our investigation.
Therefore, the study may underestimate the “true” long-term prevalence of PTSD.
Our findings refer to an average follow-up period of 2 years. Therefore, it remains
unresolved whether the proportion of diagnostic PTSD and the severity of PTSD
would further decline over time and, if so, whether such a decrease is linear and
levels off after a certain period.
The trajectory in PTSD observed in our post-MI patients cannot be deemed
to reflect the natural course of the disorder, since four patients had anti-
depressant medication and two of these had also undergone psychotherapy.
These treatments might have improved PTSD symptomatology [47]. How-
ever, our patients received non-trauma focused psychotherapy which is not
as effective as trauma-focused psychological treatments in reducing PTSD
symptoms [48].
To sum up, we found that two-thirds of post-MI patients previously diag-
nosed with clinical PTSD had maintained their diagnosis after a time course
of 2 years. Of the individual PTSD symptom clusters, it was hyperarousal
that showed most resistance to change over time. Even though the number
of patients with a diagnosis of full or subthreshold PTSD and the severity of
PTSD symptoms decreased over time, diagnostic PTSD seems to be a con-
siderably persistent condition in post-MI patients. Given that PTSD is not only
distressing for cardiac patients but has an impact on prognosis, the findings are
important clinically and may thus advocate for routine screening for PTSD in
post-MI patients.
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